Comments
Loading...

Supernus Pharmaceuticals

SUPNNASDAQ
Logo brought to you by Benzinga Data
$33.05
-1.54-4.45%
At close: -
$32.63
-0.42-1.27%
After Hours: 4:07 PM EDT
Q4 2024 Earnings in 3 days from now on Tue Feb 25th, after the market close
Conference call scheduled in 3 days at 16:30 PM Click to view the webcast

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Supernus Pharmaceuticals (SUPN)?

A

There have been no specific sales or earnings guidance reported for Supernus Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch